NCT04488913

Brief Summary

As part of the planned implementation of a new clinical pathway using hs-cTnI, the investigators will measure patient outcomes and clinical processes in a real-world scenario throughout an integrated health system across 9 emergency departments (ED).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32,609

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 19, 2020

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 28, 2020

Completed
1 day until next milestone

Study Start

First participant enrolled

July 29, 2020

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 3, 2021

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 3, 2022

Completed
Last Updated

March 23, 2022

Status Verified

March 1, 2022

Enrollment Period

8 months

First QC Date

July 19, 2020

Last Update Submit

March 21, 2022

Conditions

Keywords

high-sensitivity troponinchest pain

Outcome Measures

Primary Outcomes (1)

  • Safe ED discharge

    Proportion of patients with safe discharges home from the ED, defined as being without death or acute myocardial infarction within 30-days

    30 days after initial presentation

Secondary Outcomes (5)

  • Length of hospital stay

    From date and time of start of emergency department encounter until date and time of end of ED or hospital encounter (whichever is latest), assessed up to 7 days.

  • Number of participants with death or acute myocardial infarction

    30-day and through 1 year

  • Number of participants with revascularization or rehospitalization for cardiovascular disease

    30-days

  • Composite number of cardiology resources utilized

    30-days

  • Hospital payments received

    30-days

Other Outcomes (1)

  • Pre-specified sub-group analyses of the primary outcome

    30 days

Study Arms (2)

Standard of Care Treatment

OTHER

Exposure to traditional evaluation for suspected acute coronary syndrome (ACS) with ECG, 0- and 3-hour troponin testing using the 99th percentile as the upper reference limit, and application of the History, EKG, Age, Risk factors, and troponin (HEART) score.

Other: Standard of Care

RACE-IT pathway

ACTIVE COMPARATOR

Exposure to new protocol for suspected ACS, which includes the use of 0- and 1-hour ECG and high-sensitivity troponin testing and application of the HEAR score (a modification of the HEART score)

Other: RACE-IT Pathway

Interventions

This care pathway includes the evaluation of suspected acute coronary syndrome with high-sensitivity troponin I testing and further prognostication as needed with a modified HEART score

RACE-IT pathway

Standard of care protocol that uses the 99th percentile troponin values for evaluation of suspected acute coronary syndrome and further prognostication using the HEART score

Standard of Care Treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients ≥18 years old presenting to the ED for whom a treating clinician suspects ACS and orders a baseline ECG and cardiac troponin.

You may not qualify if:

  • ST-segment Myocardial Infarction (STEMI) leading to immediate reperfusion therapy
  • Any ED-drawn hs-cTnI value \> 99th percentile (18 ng/L)
  • Clear traumatic cause for symptoms (e.g., direct chest wall trauma, motor vehicle accident)
  • A transfer from another facility
  • Primary residence outside the state of Michigan
  • Enrolled in hospice

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Henry Ford Health System

Detroit, Michigan, 48202, United States

Location

Related Publications (3)

  • Miller J, Cook B, Gunaga S, Fadel R, Gandolfo C, Emakhu J, Mills NL, Mahler S, Levy P, Parikh S, Krupp S, Hawatian K, Nour K, Klausner H, Gindi R, Hudson M, Perrotta G, Zweig B, Lanfear D, Kim H, Danagoulian S, Keerie C, Nassereddine H, Morton T, Affas Z, Husain A, McCord J; RACE-IT Research Group. Health Care Resource Utilization for Patients With Suspected Myocardial Infarction: A Secondary Analysis of the RACE-IT Randomized Clinical Trial. JAMA Netw Open. 2025 Apr 1;8(4):e256930. doi: 10.1001/jamanetworkopen.2025.6930.

  • Glintborg D, Moller JK, Rubin KH, Lidegaard O, T'Sjoen G, Larsen MJO, Hilden M, Lehmann Christensen L, Andersen MS. Mental and Physical Health Among Danish Transgender Persons Compared With Cisgender Persons. JAMA Netw Open. 2025 Apr 1;8(4):e257115. doi: 10.1001/jamanetworkopen.2025.7115.

  • Miller J, Cook B, Singh-Kucukarslan G, Tang A, Danagoulian S, Heath G, Khalifa Z, Levy P, Mahler SA, Mills N, McCord J. RACE-IT - Rapid Acute Coronary Syndrome Exclusion using the Beckman Coulter Access high-sensitivity cardiac troponin I: A stepped-wedge cluster randomized trial. Contemp Clin Trials Commun. 2021 Apr 23;22:100773. doi: 10.1016/j.conctc.2021.100773. eCollection 2021 Jun.

MeSH Terms

Conditions

Chest PainMyocardial Ischemia

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsHeart DiseasesCardiovascular DiseasesVascular Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Stepped-Wedge Cluster Randomized
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 19, 2020

First Posted

July 28, 2020

Study Start

July 29, 2020

Primary Completion

April 3, 2021

Study Completion

March 3, 2022

Last Updated

March 23, 2022

Record last verified: 2022-03

Locations